Echo-focused differentiating points 👉:
Rhabdomyoma: Usually multiple, homogeneous echogenic masses, intramyocardial, no calcification, often in infants, tendency to regress.
Fibroma: Typically solitary, very bright echogenic mass with shadowing due to calcification, well-circumscribed, often larger, does not regress, commonly in LV free wall or septum.
To confirm LV fibroma vs rhabdomyoma, the key modality is Cardiac MRI — echo alone cannot definitively distinguish them. Here’s the clean, practical approach used clinically:
---
✅ How to Confirm LV Fibroma vs Rhabdomyoma
1. Cardiac MRI (Gold Standard)
Rhabdomyoma
T1: Iso / mildly hyperintense
T2: Hyperintense
LGE: No or minimal enhancement
Often multiple lesions
Fibroma
T1: Hypointense
T2: Hypointense
LGE: Intense, central enhancement (classic “bright core”)
Well-defined, usually solitary
→ Pattern of LGE is the single best differentiator.
---
2. Clinical Clues
Rhabdomyoma
Infant with multiple masses
Features of Tuberous sclerosis
Tumor shrinking on follow-up scan
Fibroma
Older child
Solitary, large LV wall mass
Ventricular arrhythmias (common)
---
3. Follow-up Imaging
Rhabdomyoma decreases over months
Fibroma stays same or increases → confirms fibrotic tumor
---
4. Genetic / Syndromic Workup
If rhabdomyoma suspected → Tuberous sclerosis evaluation (TSC1/TSC2)
Fibroma has no strong genetic link
---
5. Histology (rarely needed)
Only if diagnosis unclear or mass causing severe symptoms
Surgery + biopsy mainly for fibroma
---
⭐ Practical Rule
If MRI shows strong central LGE → fibroma.
If MRI shows no LGE and multiple lesions → rhabdomyoma.
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you